Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

by Radoslav Janostiak, Parmanand Malvi, Narendra Wajapeyee
Published 2019-06-01

CIP/KIP and INK4 families as hostages of oncogenic signaling

by Lucia Csergeová, David Krbušek, Radoslav Janoštiak
Published 2024-04-01

Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

by Jaydev Dave, Vineeta Jagana, Radoslav Janostiak, Malik Bisserier
Published 2023-07-01

Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease

by Malik Bisserier, Radoslav Janostiak, Frank Lezoualc’h, Lahouaria Hadri
Published 2020-01-01

Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies

by Radoslav Janostiak, Ariadna Torres-Sanchez, Francesc Posas, Eulàlia de Nadal
Published 2022-02-01

N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production

by Parmanand Malvi, Radoslav Janostiak, Arvindhan Nagarajan, Xuchen Zhang, Narendra Wajapeyee
Published 2021-06-01

Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression.

by Parmanand Malvi, Radoslav Janostiak, Arvindhan Nagarajan, Guoping Cai, Narendra Wajapeyee
Published 2019-10-01

MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway

by Radoslav Janostiak, Navin Rauniyar, TuKiet T. Lam, Jianhong Ou, Lihua J. Zhu, Michael R. Green, Narendra Wajapeyee
Published 2017-12-01